Coherus Biosciences Inc (NASDAQ: CHRS) is -33.33% lower on its value in year-to-date trading and has touched a low of $0.66 and a high of $2.64 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CHRS stock was last observed hovering at around $0.89 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $0.92, the stock is -13.16% and -23.87% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.07 million and changing 3.31% at the moment leaves the stock -28.79% off its SMA200. CHRS registered -58.92% loss for a year compared to 6-month loss of -30.82%. The firm has a 50-day simple moving average (SMA 50) of $1.20862 and a 200-day simple moving average (SMA200) of $1.292125.
The stock witnessed a -17.85% gain in the last 1 month and extending the period to 3 months gives it a -42.85%, and is -11.53% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.35% over the week and 9.35% over the month.
Coherus Biosciences Inc (CHRS) has around 306 employees, a market worth around $106.63M and $266.96M in sales. Current P/E ratio is 5.28. Profit margin for the company is 10.68%. Distance from 52-week low is 39.35% and -65.15% from its 52-week high. The company has generated returns on investments over the last 12 months (21.44%).
with sales reaching $53.68M over the same period.The EPS is expected to grow by 300.00% this year. Quarterly sales are estimated to shrink -30.34% in year-over-year returns.
Coherus Biosciences Inc (CHRS) Top Institutional Holders
166.0 institutions hold shares in Coherus Biosciences Inc (CHRS), with institutional investors hold 58.35% of the company’s shares. The shares outstanding are 115.89M, and float is at 111.28M with Short Float at 27.65%. Institutions hold 57.56% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 11.75 million shares valued at $20.33 million. The investor’s holdings represent 10.4236% of the CHRS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.6 million shares valued at $18.34 million to account for 9.4035 of the shares outstanding. The other top investors are RUBRIC CAPITAL MANAGEMENT LP which holds 10.4 million shares representing 9.0577% and valued at over $17.99 million, while TEMASEK HOLDINGS (PRIVATE) LTD holds 5.0678 of the shares totaling 5.82 million with a market value of $10.07 million.
Coherus Biosciences Inc (CHRS) Insider Activity
#####
